VISCARDIA INC has a total of 29 patent applications. It decreased the IP activity by 94.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets medical technology are SCITON INC, CLINICAL LASERTHERMIA SYSTEMS AB and KONA MEDICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 |
# | Industry | |
---|---|---|
#1 | Medical technology |
# | Technology | |
---|---|---|
#1 | Electrotherapy | |
#2 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Bauer Peter T | 28 |
#2 | Chinchoy Edward | 19 |
#3 | Snell Jay | 19 |
#4 | Arand Patricia A | 6 |
#5 | Wheeler Timothy | 4 |
#6 | Bauer Peter | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021061793A1 | Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health | |
WO2018067274A1 | Systems, device, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation | |
US2017312508A1 | Implantable medical devices, systems, and methods for selection of optimal diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity | |
US2017021166A1 | Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation | |
US2014172040A1 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation |